Paper149772
An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice.
Ojo E and 3 others. Int J Cancer, 1978. Cited by 114 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice. Papers, record 149772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/149772
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Neoplasms, Experimental | Major topic |
| Propionibacterium acnes | Major topic |
| Animals | |
| Cell Line | |
| Cytotoxicity Tests, Immunologic | |
| Immunotherapy | |
| Injections, Intraperitoneal | |
| Injections, Intravenous | |
| Lymphocyte Culture Test, Mixed | |
| Mice | |
| Mice, Inbred Strains | |
| T-Lymphocytes |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,101,861 | Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. | J Exp Med | 1993 | https://conductscience.org/library/papers/8101861 | PubMed |
| 7,451,553 | The in vivo cytostatic effect induced by Propionibacterium granulosum on murine tumor cells. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/7451553 | PubMed |
| 7,203,558 | Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens. | Immunogenetics | 1981 | https://conductscience.org/library/papers/7203558 | PubMed |
| 7,185,419 | Role of natural killer cells in control of cancer metastasis. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/7185419 | PubMed |
| 7,068,208 | Cytotoxic cells induced after Chlamydia psittaci infection in mice. | Infect Immun | 1982 | https://conductscience.org/library/papers/7068208 | PubMed |
| 7,061,569 | Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/7061569 | PubMed |
| 7,012,001 | Effect of route of Mycobacterium bovis BCG administration on induction of suppression of sporozoite immunity in rodent malaria. | Infect Immun | 1981 | https://conductscience.org/library/papers/7012001 | PubMed |
| 6,968,570 | Factors affecting stimulation of natural cytotoxicity to a rat lymphoma by Corynebacterium parvum. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6968570 | PubMed |
| 6,610,680 | Studies on natural killer cell activity and the influence of Corynebacterium parvum on murine T-cell leukemogenesis induced by butylnitrosourea. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6610680 | PubMed |
| 6,350,312 | The seeding of a transplanted murine leukemia and its influence on hemopoietic stem cells and immune function of the host. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6350312 | PubMed |
| 6,347,362 | Cellular suppression of murine ADCC and NK activities induced by Corynebacterium parvum. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6347362 | PubMed |
| 6,332,113 | Leukemia induction by methylnitrosourea (MNU) in selected mouse strains. Effects of MNU on hemopoietic stem cells, the immune system and natural killer cells. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6332113 | PubMed |
| 6,263,794 | Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type. | Immunology | 1981 | https://conductscience.org/library/papers/6263794 | PubMed |
| 6,215,354 | Kinetics of immunosuppression of sporozoite-induced immunity by Mycobacterium bovis BCG. | Infect Immun | 1982 | https://conductscience.org/library/papers/6215354 | PubMed |
| 6,203,638 | Natural killer cells in human solid tumors. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6203638 | PubMed |
| 6,191,859 | Antitumor activity of living or killed Brucella: modification of the non-specific cytotoxic effector cells. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6191859 | PubMed |
| 6,166,566 | Protection of mice against mouse hepatitis virus by Corynebacterium parvum. | Infect Immun | 1981 | https://conductscience.org/library/papers/6166566 | PubMed |
| 3,899,934 | Induction of natural killer cell activity by inactivated Candida albicans in mice. | Infect Immun | 1985 | https://conductscience.org/library/papers/3899934 | PubMed |
| 3,876,679 | The effect of treatment with Corynebacterium parvum on the development and growth of experimental hematogenic metastases of schwannoma in the rat. | Acta Neuropathol | 1985 | https://conductscience.org/library/papers/3876679 | PubMed |
| 3,484,675 | Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3484675 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/149772
GET https://conductscience.org/api/papers/v1/149772/cited_by?page=2